top of page
Psychiatric Disease Treatments
Operator of drug discovery platform intended to develop novel FDA-approved psychoactive medicines. The company's platform leverages plant derived compounds to accelerate the development of novel therapeutics, enabling physicians with the treatment and prevention of psychiatric and neurological disorders.
Sensorium is conducting clinical studies at CU Anschutz to evaluate their lead candidate therapeutic.
bottom of page